OncoImmune competitorsClear all
InnoCare's top competitors include Halozyme Therapeutics.
 InnoCare InnoCare is a biopharmaceutical company specializing in drug development for the treatment of cancer and autoimmune diseases. |  Halozyme Therapeutics Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. | |
Founding Date | Founding Date 2013 | Founding Date 1998 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations CN HQ Nanjing Shi, CN Cambridge, US Princeton, US | Locations San Diego, US HQ |
Employees | Employees 841% decrease | Employees 1363% increase |
Employee Rating | Employee Rating 4 | Employee Rating 3.3 |
Funding | ||
Total funding raised | Total funding raised $ 215m | Total funding raised $ 45m |
For sources of this data, please see the company profile
View company profiles
Halozyme Therapeutics
HQ
San Diego, US
Employees
136↑ 3% increase
Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View company